Annexon's top three insider shareholders as of April 28, 2026 are Muneer A Satter (Director, 9.73Mn shares), Muneer A Satter (Director, 9.73Mn shares), Capital Life Sciences Investors, Llc Bain (TenPercentOwner, 5.70Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Muneer A Satter | - | 0 | 9,728,637 | 21 Nov, 2025 |
| Muneer A Satter | - | 0 | 9,728,637 | 21 Nov, 2025 |
| Capital Life Sciences Investors, Llc Bain | - | 0 | 5,701,926 | 30 May, 2023 |
| Capital Life Sciences Investors, Llc Bain | - | 0 | 5,701,926 | 30 May, 2023 |
| Douglas Love | President And Ceo | 351,554 | 0 | 18 Feb, 2025 |
| Douglas Love | President And Ceo | 351,554 | 0 | 18 Feb, 2025 |
| Michael Overdorf | Evp Chief Business Officer | 182,625 | 0 | 04 Mar, 2026 |
| Michael Overdorf | Evp Chief Business Officer | 182,625 | 0 | 04 Mar, 2026 |
| Dean Richard Artis | Evp Chief Scientific Officer | 180,093 | 0 | 04 Mar, 2026 |
| Jennifer Lew | Evp Chief Financial Officer | 170,700 | 0 | 04 Mar, 2026 |
| Jennifer Lew | Evp Chief Financial Officer | 170,700 | 0 | 04 Mar, 2026 |
| Ted Yednock | Evp Chief Innovation Officer | 154,161 | 0 | 04 Mar, 2026 |
| Ted Yednock | Evp Chief Innovation Officer | 154,161 | 0 | 04 Mar, 2026 |
| Jamie Dananberg | Chief Medical Officer | 123,582 | 0 | 04 Mar, 2026 |
| Jamie Dananberg | Chief Medical Officer | 123,582 | 0 | 04 Mar, 2026 |
| William H. Carson | - | 70,405 | 0 | 14 Apr, 2026 |
| Jung Choi | - | 0 | 33,000 | 03 Dec, 2025 |
| Jung Choi | - | 0 | 33,000 | 03 Dec, 2025 |
| Larry Mattheakis | Evp Chief Scientific Officer | 17,188 | 0 | 13 Jul, 2022 |
| Larry Mattheakis | Evp Chief Scientific Officer | 17,188 | 0 | 13 Jul, 2022 |
| Sanjay Keswani | Evp Chief Medical Officer | 12,500 | 0 | 15 Feb, 2022 |
| Sanjay Keswani | Evp Chief Medical Officer | 12,500 | 0 | 15 Feb, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 10 Apr, 2026 | William H. Carson | Common Stock | A | 8,000 | $6.20 | 70,405 | D | P |
| 10 Mar, 2026 | William H. Carson | Common Stock | A | 8,000 | $5.67 | 62,405 | D | P |
| 02 Mar, 2026 | Michael Overdorf | Common Stock | D | 4,339 | $5.42 | 182,625 | D | S |
| 02 Mar, 2026 | Jennifer Lew | Common Stock | D | 5,565 | $5.42 | 170,700 | D | S |
| 02 Mar, 2026 | Jennifer Lew | Common Stock | D | 5,565 | $5.42 | 170,700 | D | S |
| 02 Mar, 2026 | Jamie Dananberg | Common Stock | D | 5,820 | $5.43 | 123,582 | D | S |
| 02 Mar, 2026 | Ted Yednock | Common Stock | D | 5,566 | $5.42 | 154,161 | D | S |
| 02 Mar, 2026 | Dean Richard Artis | Common Stock | D | 5,894 | $5.43 | 180,093 | D | S |
| 02 Mar, 2026 | Jamie Dananberg | Common Stock | D | 5,820 | $5.43 | 123,582 | D | S |
| 02 Mar, 2026 | Ted Yednock | Common Stock | D | 5,566 | $5.42 | 154,161 | D | S |
| 02 Mar, 2026 | Michael Overdorf | Common Stock | D | 4,339 | $5.42 | 182,625 | D | S |
| 19 Feb, 2026 | Ted Yednock | Common Stock | A | 62,500 | $0.00 | 159,727 | D | A |
| 19 Feb, 2026 | Dean Richard Artis | Common Stock | A | 62,500 | $0.00 | 185,987 | D | A |
| 19 Feb, 2026 | Michael Overdorf | Common Stock | A | 62,500 | $0.00 | 186,964 | D | A |
| 19 Feb, 2026 | Jennifer Lew | Common Stock | A | 62,500 | $0.00 | 176,265 | D | A |
| 19 Feb, 2026 | Ted Yednock | Common Stock | A | 62,500 | $0.00 | 159,727 | D | A |
| 19 Feb, 2026 | Michael Overdorf | Common Stock | A | 62,500 | $0.00 | 186,964 | D | A |
| 19 Feb, 2026 | Jamie Dananberg | Common Stock | A | 56,250 | $0.00 | 129,402 | D | A |
| 19 Feb, 2026 | Douglas Love | Stock Option (Right to Buy) | A | 1,250,000 | $0.00 | 1,250,000 | D | A |
| 19 Feb, 2026 | Douglas Love | Stock Option (Right to Buy) | A | 1,250,000 | $0.00 | 1,250,000 | D | A |